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Abstract
Coagulase-negative staphylococci, ubiquitous commensals of human skin, and mucous membranes represent important patho-
gens for immunocompromised patients and neonates. The increasing antibiotic resistance among Staphylococcus epidermidis is
an emerging problem worldwide. In particular, the linezolid-resistant S. epidermidis (LRSE) strains are observed in Europe since
2014. The aim of our study was to genetically characterize 11 LRSE isolates, recovered mostly from blood in the University
Children’s Hospital in Krakow, Poland, between 2015 and 2017. For identification of the isolates at the species level, we used
16S rRNA sequencing and RFLP of the saoC gene. Isolates were characterized phenotypically by determining their antimicrobial
resistance patterns and using molecular methods such as PFGE,MLST, SCCmec typing, detection of the ica operon, and analysis
of antimicrobial resistance determinants. All isolates were multidrug-resistant, including resistance to methicillin, and exhibited
so-called PhLOPSA phenotype. In PFGE, all isolates (excluding one from a catheter) represented identical patterns, were
identified as ST2, and harbored the ica operon, responsible for biofilm formation. Linezolid resistance was associated with
acquisition of A157R mutation in the ribosomal protein L3 and the presence of cfr gene. All isolates revealed new SCCmec
cassette element composition. Recently, pediatric patients with serious staphylococcal infections are often treated with linezolid.
The increasing linezolid resistance in bacterial strains becomes a real threat for patients, andmonitoring such infections combined
with surveillance and infection prevention programs is very important to decrease number of linezolid-resistant staphylococcal
strains.
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Introduction
Coagulase-negative staphylococci (CoNS) ubiquitously
colonize human skin and mucosal membranes, and due to
this fact, they were for a long time considered harmless
commensals [1]. Nowadays, however, they are increasing-
ly important etiologic agents of hospital-acquired infec-
tions (HAIs), including central line-associated bloodstream
infections (CLABSIs) and surgical-site infections (SSIs).
Among human CoNS, Staphylococcus epidermidis repre-
sents the most frequently isolated species [2]. The increas-
ing prevalence of antibiotic-resistant CoNS from nosoco-
mial infections have been reported in Europe for some time
[3–6], including especially worrisome methicillin-resistant
S. epidermidis (MRSE) [7]. Since 2000, linezolid, a repre-
sentative of the oxazolidynones has become an important
addition in treatment for uncomplicated and complicated
skin and skin structure infections and hospital- and
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community-acquired pneumonia caused by Gram-positive
pathogens [8]. Shortly after the introduction into hospital
practice, the first case of linezolid-resistant Staphylococcus
aureus was reported in the USA in 2001 [9]. Linezolid-
resistant S. epidermidis (LRSE) are increasingly observed
in European countries, such as Portugal, Germany, Greece,
Italy, Ireland, and France [10–17]. Linezolid resistance de-
terminants may be acquired by staphylococci due to muta-
tions selected during prolonged linezolid therapy and by
horizontal gene transfer [18–21]. The G2576T mutation in
the loop Vof 23S rRNA is the principal determinant of the
resistance; however, other mutations such as C2190T,
T2502A, C2532T, and G2603T are observed as well [11,
22–24]. Mutations in the genes of ribosomal proteins L3
(rplC gene), L4 (rplD gene), and L22 (rplV gene) are also
relatively frequently encountered among LRSE [8]. As
reviewed by Mendes et al. [8], the alterations in L3 and
L4 as a resistance mechanism appeared later in time and
the complexity and number of such alterations in LRSE
increased since 2014. The A157R modification in L3 was
observed in the USA and Italy up to date [8]. Transferable
genes conferring linezolid resistance in staphylococci in-
clude the cfr gene encoding ribosomal methyltransferase
gene and the optrA and poxtA genes of ribosomal protec-
tion proteins [25–28]. Among these, only cfr was reported
among LRSE so far [29]. Next emerging problem is that
linezolid and methicillin resistance are often combined, so
it is also important to characterize the SCCmec cassette
elements in such isolates [16, 30–31].
Here, we present a report on a possible LRSE spread in the
University Children’s Hospital (UCH) in Krakow, Poland,
between 2015 and 2017. The aim of this study was to genet-
ically characterize the LRSE strains, determine their clonal
relationships, linezolid resistance mechanisms and refer the
results to patients’ characteristics.
Materials and methods
Bacterial isolates
The study included 11 LRSE clinical isolates recovered be-
tween 2015 and 2017 from the UCH in Krakow from 10
pediatric patients aged from 23 days to 11 months. Nine iso-
lates were recovered from blood (including two isolates from
the same patient), one from a throat and one from a central
venous catheter. All isolates were recovered after at least 48 h
after admission to the unit. Linezolid resistance was detected
in the hospital laboratory based on disc-diffusion method (li-
nezolid (30 μg)). The preliminary identification of isolates
was performed with BD Phoenix™ system (Becton
Dickinson, Franklin Lakes, NJ, USA).
Genomic DNA extraction
For genomic DNA extraction, isolates were grown for 18–
20 h at 37 °C on blood agar plates. A full inoculation loop
of 10 μl of bacterial colonies was homogenized with a
TissueLyser II (Qiagen, Germantown, MD, USA). Total
DNAwas extracted by enzymatic lysis using the buffers and
solutions provided with the DNeasy Blood and Tissue Kit
(Qiagen, Germantown, MD, USA) according to manufac-
turer’s instructions.
Species identification
All isolates were identified at the species level by sequencing
of 16S rRNA as previously described [32] and PCR-RFLP of
the saoC gene [33]. The 16S rRNA gene was amplified with
slight modifications in PCR program: initial denaturation for
2 min at 94 °C, then followed by 25 cycles of denaturation at
94 °C for 30 s, annealing at 58 °C for 30 s, and extension at
72 °C for 60 s. The final extension was for 5 min at 72 °C. The
PCR products were resolved by electrophoresis and purified
using the DNA Clean & Concentrator™-5 purification kit
(Zymo Research, Irvine, CA, USA). Two hundred nanograms
of PCR product was used for sequencing with the primers
used for PCR amplification. The saoC gene was amplified
with the set of seven primers described previously [33]. PCR
products were digested separately using each enzyme from the
set of restriction enzymes (TaiI, Tsp509I, AluI, and MseI
(Thermo Fisher Scientific, Waltham, MA, USA)). The obtain-
ed restriction patterns were compared to saoC gene fingerprint
of the reference S. epidermidis strain.
Susceptibility testing
Methicillin resistance was initially identified using cefoxitin
disks (30 μg) (Oxoid Ltd., Cambridge, UK), and the pheno-
type was further confirmed by the detection of the mecA gene
[34]. MIC values for linezolid, ceftarolin, vancomycin,
teicoplanin, dalbavancin, daptomycin, and fosfomycin were
determined using the Etest method (bioMérieux, Marcy
l’Etoile, France); MIC of ciprofloxacin was determined by a
broth microdilution method according to the European
Committee on Antimicrobial Susceptibility Testing
(EUCAST; www.eucast.org); for rifampin, tetracycline,
minocycline, tigecycline, chloramphenicol, and gentamicin,
the disk-diffusion method was used following the EUCAST
recommendations. The results were interpreted using the
EUCASTcriteria. The S. aureus strain ATCC 29213 was used
as a control. Inducible clindamycin resistance was tested by
placing the erythromycin and clindamycin double-disk test
according to the EUCAST recommendations.
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Molecular typing, analysis of antimicrobial resistance
determinants, and detection of the ica operon
The clonality of isolates was studied using the pulsed-field
electrophoresis (PFGE) of SmaI-digested bacterial DNA em-
bedded in agarose plugs, as described by others [35] and the
multilocus sequence typing (MLST) [36]. To assign alleles
and sequence types (STs) for allelic profiles, the
S. epidermidis MLST website (https://pubmlst.org/
sepidermidis/; 24th October 2019, date last accessed) was
used [37]. The SCCmec cassettes were typed with two inde-
pendent methods as described previously by Milheirico et al.
[38] and Kondo et al. [34] with USA300 3956/13 strain as a
positive control for IV SCCmec cassette.
Detection of the cfr and optrA genes was performed as
previously, using strains from the laboratory collection as pos-
itive controls [39]. Presence of aac(6′)-Ie-aph(2″) and struc-
ture of Tn4001were studied as described [40] with the control
strains characterized previously [41]. For the poxtA, fexA,
norA, fosB and the ica operon detection by PCR and for
rplC, rplD, rplV and the 23S rRNA gene sequencing primers
were designed in the current study (Table 1).
Nucleotide sequence accession numbers
The 16S rRNA gene sequences were annotated using the




We evaluated 10 patients (newborns and infants) age 23 days
to 11 months at the time of the LRSE isolation; weight 915 to
6400 g on the day of admission to UCH. Four patients were
small for gestational age (SGA), and no data was available for
2 patients. All patients were transferred from five different
hospitals in Krakow or Lesser Poland. With an exception of
one patient, all patients had at least one birth defect (Table 2).
After transfer to the UCH, patients were admitted to two dif-
ferent Intensive Care Units: ICU 1 (n = 8) and ICU 2 (n = 2).
All patients had indwelling central venous catheters. During
the hospitalization, nine patients were transferred to another
ward once or twice. The infection due to LRSEwas diagnosed
within 7 to 331 day after hospital admission. All LRSE iso-
lates were recovered after at least 48 h after admission to the
unit so the criterion of HAI is fulfilled. Patients were diag-
nosed with sepsis, fever, oliguria, and chronic respiratory fail-
ure. All patients underwent from one to six surgery operations.
The values of infectious markers such as leukocytosis, the C-
reactive protein (CRP), and procalcitonin (PCT) are presented
in Table 2. At the time of LRSE isolation, six patients were
treated with linezolid, but all patients were treated with linez-
olid at least once during hospitalization (Table 2). Figure 1
shows the time of patient hospitalization, LRSE detection,
and date of patient discharge.
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Characteristics of isolates and species identification
A total of 11 isolates from blood (n = 9), throat (n = 1),
and central venous catheter (n = 1) collected from pediat-
ric ICUs patients were investigated. Two isolates (K/15/
9696 and K/15/9821) were collected from the same pa-
tient, 23 and 27 days after hospitalization, respectively.
The preliminary identification with BD Phoenix™ system
identified seven isolates as S. epidermidis and three iso-
lates as Staphylococcus hominis. The obtained 16S rRNA
sequences, identical for all studied isolates, were analyzed
using nucleotide BLAST (Basic Local Alignment Search
Tool, http://www.ncbi.nlm.nih.gov/BLAST/) and aligned
to the reference sequences deposited in the GenBank
and leBIBI databases. Using the previously described
criteria for Staphylococcus identification at the species
level [42–43], the best and the second-best species align-
ments were analyzed, and all isolates were identified as
S. epidermidis. The identification as S. epidermidis was
additionally confirmed with the saoC gene restriction
analysis.
Molecular typing and ica detection
PFGE analysis included 10 isolates into the subtype 1A and
the remaining isolate from a catheter into the related pulsotype























































date of the isolation
date of discharge
Fig. 1 Dates of patient
hospitalization and isolation of
LRSE
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Antimicrobial susceptibility and resistance
determinants
Eleven investigated isolates fully shared their antimicrobial
susceptibility profiles. All isolates remained susceptible to
vancomycin, teicoplanin, daptomycin, ceftaroline, tetracy-
cline, minocycline, tigecycline, rifampin, and erythromycin.
All isolates showed high resistance to linezolid (MIC above
256 mg/L) together with resistance to chloramphenicol and
clindamycin, consistent with the presence of cfr, rendering
so-called PhLOPSA phenotype [44]. No inducible
clindamycin resistance was detected. The chloramphenicol-
resistance gene, fexA, was also observed in the whole group.
Additionally, the isolates demonstrated the A157R change in
their deduced amino acid sequences of the L3 protein. No
changes occurred in the analyzed part of 23S rRNA genes
and in the L4 and L22 protein genes. The isolates also dem-
onstrated resistance to methicillin, ciprofloxacin, fosfomycin,
and gentamicin, and in agreement with these phenotypes, all
isolates were positive for mecA, norA, fosB, and aac(6′)-Ie-
aph(2″) located in the complete Tn4001 transposon.
Altogether, the isolates were resistant to six various classes
of antimicrobials, i.e., they were multidrug resistant [45].
SCCmec cassettes typing
In both SCCmec typing methods, all isolates revealed new
composition of the SCCmec cassette. All LRSE strains har-
bored: mecA, mecI, SCCmecIII J1, and dcs genes which indi-
cates the mixture of SCCmec type II and III cassette elements
[38]. Despite the dcs, mecI, and mecA genes, the SCCmec II
cassette includes kdp and ccrB genes which were not detected
in LRSE isolates. Although, all 11 isolates had SCCmecIII J1
gene which is a component of SCCmec III but they did not
harbor RIF gene. The Kondo typing method [34] showed that
all 11 LRSE isolates possessed class A of mecA gene and two
ccr complexes (ccrAB3 and ccrAB4).
Discussion
Linezolid is an effective treatment for multidrug-resistant
Gram-positive bacteria and despite its broad use for almost
20 years, it still exhibits excellent activity against staphylo-
cocci. Linezolid resistance among S. epidermidis remains un-
common worldwide but the increasing resistance in European
countries such as Greece, Spain, Portugal, Italy, France, and
Ireland has been reported [10–17]. The LRSE outbreaks occur
occasionally and are mainly associated with ICUs [15]. Here,
we describe the first emergence of LRSE and MRSE in
Poland in a pediatric ICU. The emergence of LRSE strains
is associated with an increased prior linezolid usage. In our
hospital, linezolid was introduced into practice in 2005. The
first LRSE strain was isolated from cerebrospinal fluid at
12.01.2014 from the Oncology and Hematology
Department. Since 2015, the increased number of LRSE was
isolated from invasive infections with a highest number of
isolates in 2017.
Pediatric patients are at particular risk of bacterial infec-
tions due to their immature immune system, and this risk is
especially evident in premature newborns and babies under-
going medical procedures, such as surgery, presence of cath-
eters, and prolonged/extensive antimicrobial treatment.
Restriction of linezolid usage was associated with disappear-
ance of the resistant strains from the affected ICU.
In Poland, the nosocomial S. epidermidis population is
dominated by strains belonging to MLST clonal complex 2
(CC2) [http://eburst.mlst.net]. These clones are multiresistant,
seem to persist in hospital environment, and evolve quickly
due to mutations, recombination events, and frequent
transmission of mobile genetic elements [46]. In the present
study, all isolates belonged to ST2, a presumable ancestral
type of CC2. In Germany, in 2015, Bender et al. described
12 (33%) LRSE belonging to ST2 [11], O’Connor et al.
described 9 isolates (100%) as ST2 [13], and Barros et al.
described one in a Portuguese hospital [10]. In 2018, Dortet
et al. described an outbreak caused by ST2, ST5, and ST22 of
LRSE in France [15]. In other European countries, five
different STs were identified: (i) ST22 in Greece, Germany,
and Spain [11–12, 16, 31]; (ii) ST23 in Italy and Germany [11,
14, 16]; (iii) ST83 in Italy [14]; and (iv and v) ST5 and ST168
in Germany [11, 16].
PFGE analyses are widely used for detection of the spread
of a single clone at the local level [47], and we also applied
this technique in our study. The restriction patterns of SmaI
revealed two closely related PFGE types among isolates.
Furthermore, all isolates shared the antimicrobial resistance
phenotypes and determinants. Linezolid resistance was asso-
ciated with acquisition of the A157Rmutation in the ribosom-
al protein L3 and the presence of cfr gene. Such L3 alterations
were described previously to impact linezolid susceptibility
[48–49]. As shown in other studies, the cfr gene can co-
occur with other linezolid resistance mechanisms [26,
50–51]. Importantly, the presence of a highly similar cfr plas-
mids in different genetic backgrounds was confirmed [17],
and their acquisition via horizontal gene transfer in LRSE
has been shown [11, 14]. The evidence for the presence of
endemic LRSE clones that circulate in hospital settings was
also reported [10, 12]. These strains differ from commensal
S. epidermidis isolates and become more successful in the
hospital environment [6]. All isolates carried also the
icaADBC locus, which is responsible for the production of
polysaccharide intercellular adhesin (PIA), playing an impor-
tant role in formation of biofilm by the bacterium [52–53].
Since, the linezolid have been used to treat biofilm-
associated S. epidermidis infections, the circulation of LRSE
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with a biofilm-associated operon constitutes a real threat for
patients [54–55].
All studied isolates shared also the atypical composition of
their SCCmec elements. Such situation is indeed observed in
MRCoNS also by others [3, 56]. Chen et al. showed the multiple
ccr complexes composition in CoNS strains. The authors
showed the ccrAB3 and ccrAB4 genes in S. hominis and
S. capitis [57]. Our study revealed not only the multiple ccr but
also a combination of SCCmec cassette II and III elements in all
our LRSE strains. The detection of new SCCmec cassettes com-
position of all LRSE strains revealed the acquisition of antibiotic
resistance determinantswithin hospital environment and revealed
that CoNS strains are a reservoir of antibiotic resistance genes
which can be easily spread to S. aureus strains. To fully elucidate
the structure of SCCmec element in studied isolates, the whole-
genome sequencing is indispensable.
In conclusion, we have reported the first emergence of
LRSE in Poland. Recently, linezolid is used more frequently,
especially in pediatric patients for treatment of severe infec-
tions. As the ST2 LRSE is identified not only in Poland but in
many European countries, it is very important to start or con-
tinue the surveillance, infection control, and antimicrobial
guidelines against linezolid-resistant staphylococcal strains.
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